2015
DOI: 10.1186/s12953-015-0071-8
|View full text |Cite
|
Sign up to set email alerts
|

Comparative proteomics of Bt-transgenic and non-transgenic cotton leaves

Abstract: BackgroundAs the rapid growth of the commercialized acreage in genetically modified (GM) crops, the unintended effects of GM crops’ biosafety assessment have been given much attention. To investigate whether transgenic events cause unintended effects, comparative proteomics of cotton leaves between the commercial transgenic Bt + CpTI cotton SGK321 (BT) clone and its non-transgenic parental counterpart SY321 wild type (WT) was performed.ResultsUsing enzyme linked immunosorbent assay (ELISA), Cry1Ac toxin protei… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
27
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(29 citation statements)
references
References 56 publications
1
27
0
Order By: Relevance
“…Comparative omics analyses have been performed comparing GMO crops and their isogenic counterpart. A number of them have shown metabolic disturbances from potential unintended effects of the GM transformation process in Bt maize9101112, glyphosate-tolerant soybean131415, potato16, cotton17 and rice18. However, these studies do not report consistent or coherent results, which can be explained by the use of a variety of genetic backgrounds and/or different growth conditions, as well as variations in the technologies and threshold levels applied19.…”
mentioning
confidence: 99%
“…Comparative omics analyses have been performed comparing GMO crops and their isogenic counterpart. A number of them have shown metabolic disturbances from potential unintended effects of the GM transformation process in Bt maize9101112, glyphosate-tolerant soybean131415, potato16, cotton17 and rice18. However, these studies do not report consistent or coherent results, which can be explained by the use of a variety of genetic backgrounds and/or different growth conditions, as well as variations in the technologies and threshold levels applied19.…”
mentioning
confidence: 99%
“…It includes: (1) the evaluation of the RNAi cultivar for desired trait expression; (2) experimental quantification of the gene-knockdown level of targeted gene expression; and (3) comparative sequencing of siRNA sequence profile before and after RNAi. Although currently not validated within the regulatory framework for food safety assessment, additionally, comparative studying of proteome and metabolome profiles of RNAi cultivar/product may be considered ( Ricroch et al, 2011 ; Clarke et al, 2013 ; Simó et al, 2014 ; Wang et al, 2015b ). These steps could identify any “off-target” phenotypes, visible side effects, production of unexpected novel siRNA or/and secondary RNA signatures as well as unknown proteome/metabolome components in RNAi cultivar genome and its products.…”
Section: Safety and Risk Assessmentsmentioning
confidence: 99%
“…Transgenic technology has brought many promising GM plants with improved quality and/or enhanced stress tolerance and has also allowed microelement non-accumulators to accumulate trace minerals and common plants to hyperaccumulate them. Lots of work has been done to compare GM crops and their non-transgenic counterparts (Yang et al, 2013 ; Wang L. et al, 2015 ). These comparative analyses were mostly conducted by proteomics methods, which mainly use two-dimensional electrophoresis (2-DE) coupled with mass spectrometry (MS) to distinguish differential proteins or protein content between GM crops and their wild types (Barros et al, 2010 ; Brandão et al, 2010 ; Yang et al, 2013 ; Wang L. et al, 2015 ).…”
Section: Discussion and Future Prospectsmentioning
confidence: 99%
“…Lots of work has been done to compare GM crops and their non-transgenic counterparts (Yang et al, 2013 ; Wang L. et al, 2015 ). These comparative analyses were mostly conducted by proteomics methods, which mainly use two-dimensional electrophoresis (2-DE) coupled with mass spectrometry (MS) to distinguish differential proteins or protein content between GM crops and their wild types (Barros et al, 2010 ; Brandão et al, 2010 ; Yang et al, 2013 ; Wang L. et al, 2015 ). Metabolomics techniques such as HPLC, NMR, and GC/MS have also been used to analyze differences between metabolites including carbohydrates, lipids, and amino acids (Brandão et al, 2010 ).…”
Section: Discussion and Future Prospectsmentioning
confidence: 99%